Citigroup resumed coverage on Merck with a new price target

robot
Abstract generation in progress

Citigroup has resumed coverage on Merck (MRK) with a new price target of $125.00, as reported by Quantisnow. This update comes amidst recent analyst ratings and several insider transactions for Merck & Company Inc. The article also provides a summary of recent analyst ratings and insider trading activity for the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned